Kaneh Bosm Biotechnology Inc. — Form D
Kaneh Bosm Biotechnology Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2018-07-12. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Other.
Offering
- Filed: 2018-07-12
- Form: D
- Accession: 0001052918-18-000269
- Industry: Other
- Exemptions: 06b
- Total offering: $2.5M
- Amount sold: $2.5M
- Investors: 1
- Date of first sale: 2018-06-28
- Security types: equity
- Revenue range: Not Applicable
- SEC file number: 021-316747
Issuer
- Name: Kaneh Bosm Biotechnology Inc.
- CIK: 0001743067
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 810 - 789 WEST PENDER STREET, VANCOUVER, A1, V6C1H2
- Phone: 6046872038
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Kent Ausburn | Director | Vancouver, A1 |
| Eugene Beukman | Director | Vancouver, A1 |
| Michael Martinz | Director | Vancouver, A1 |
| Brendan Purdy | Director | Arlington, MA |
| Eugene Beukman | Executive Officer | Vancouver, A1 |
| Peter Nguyen | Executive Officer | Vancouver, A1 |
| Michael Martinz | Executive Officer | Vancouver, A1 |
| Rudy de Jonge | Director | Vancouver, A1 |
| Rudy de Jonge | Executive Officer | Vancouver, A1 |
Other filings by this issuer (2)
More